Rhopressa
Netarsudil · Alcon Laboratories, Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Rhopressa ingredients
| Active ingredient | Strength |
|---|---|
| Netarsudil Mesylate | .2 mg/mL |
What Rhopressa is used for
Rhopressa is a cancer medicine (rho kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Rhopressa
- Generic name
- Netarsudil
- Made by
- Alcon Laboratories, Inc.
- Forms
- Solution/ Drops
- Given
- Ophthalmic, Topical
- Drug class
- Rho Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA208254
- On the US market since
- 2017
Official information
- Rhopressa prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Netarsudil)
In India
- Netarsudil mesylate: 3 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Rhopressa?
Rhopressa (Netarsudil) is a cancer medicine made by Alcon Laboratories, Inc., approved by the US FDA.
What are the ingredients of Rhopressa?
Rhopressa contains Netarsudil Mesylate (.2 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA